Apogee Therapeutics
The Associate Director of Biostatistics will act as the statistical lead for one or multiple clinical development projects, providing technical leadership across study design, planning, execution, and scientific publications. The role partners closely with cross-functional teams to provide biostatistical input for development plans, regulatory interactions, and study interpretation while ensuring statistical integrity and high-quality deliverables. The position involves oversight of vendor/CRO biostatistics, contributions to regulatory submissions, and participation in company meetings and occasional travel.
Headquarters
San Francisco, California, United States
Company Size
51-200 employees
Founded
2022
Apogee Therapeutics is a clinical-stage biotechnology company developing differentiated biologics for immunological and inflammatory diseases. The company focuses on high-unmet-need conditions including atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), asthma and other I&I disorders. Apogee advances therapeutic candidates through clinical development with the goal of delivering best‑in‑class treatments for patients with inflammatory and immune-mediated diseases.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Apogee Therapeutics.
A Look At Apogee Therapeutics (APGE) Valuation After Wider Losses And A New Shelf Registration
2 days ago